(MedPage Today) — Researchers reported that they successfully used targeted therapy to treat a rare and aggressive T-cell lymphoma that developed after chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma.
A 51-year-old patient…
Source link : https://www.medpagetoday.com/hematologyoncology/hematology/117130
Author :
Publish date : 2025-08-22 21:33:00
Copyright for syndicated content belongs to the linked Source.
